HM781-36,
HM781-36B,
poziotinib,
Poziotinib,
1092364-38-9,
UNII-OEI6OOU6IK,
HM781-36B,
NOV120101,
OEI6OOU6IK,
Poziotinib (HM781-36B),
NOV-120101,
1-(4-((4-((3,4-dichloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)prop-2-en-1-one,
1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)prop-2-en-1-one,
2-Propen-1-one, 1-[4-[[4-[(3,4-dichloro-2-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-1-piperidinyl]-,
1-[4-[[4-[(3,4-Dichloro-2-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-1-piperidinyl]-2-propen-1-one,
Poziotinib [INN],
HM-78136B,
Tube707,
poziotinib-hm781-36b,
GTPL7903,
SCHEMBL3391764,
CHEMBL3545154,
DTXSID80148853,
EX-A528,
LPFWVDIFUFFKJU-UHFFFAOYSA-N,
BCP08270,
MFCD28044290,
s7358,
ZINC95930125,
AKOS026674078,
CS-3942,
DB12114,
HM-781-36B,
NOV 120101,
SB16882,
NCGC00386427-01,
AC-29021,
AK198898,
BC600633,
DA-47945,
HY-15730,
B5827,
FT-0752903,
A13044,
J-690026,
1-[4-[4-(3,4-dichloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]prop-2-en-1-one,
1-[4-[4-(3,4-Dichloro-2-fluorophenylamino)-7-methoxyquinazoline-6-yloxy]-1-piperidinyl]-2-propene-1-one,
VARLITINIB,
D00YER,
ACN-037459,
Pan-Her/EGFR inhibitors (cancer), Hanmi,